Multimodal radiomics-based methods using deep learning for prediction of brain metastasis in non-small cell lung cancer with 18F-FDG PET/CT images

被引:0
作者
Zhu, Yuan [1 ,2 ]
Cong, Shan [2 ]
Zhang, Qiyang [1 ]
Huang, Zhenxing [1 ]
Yao, Xiaohui [2 ]
Cheng, You [3 ]
Liang, Dong [1 ,4 ]
Hu, Zhanli [1 ,4 ]
Shao, Dan [3 ]
机构
[1] Chinese Acad Sci, Shenzhen Inst Adv Technol, Lauterbur Rese Ctr Biomed Imaging, Shenzhen 518055, Peoples R China
[2] Harbin Engn Univ, Qingdao Innovat & Dev Ctr, Qingdao 266000, Peoples R China
[3] Southern Med Univ, Guangdong Prov Peoples Hosp, Guangdong Acad Med Sci, Dept Nucl Med, Guangzhou, Peoples R China
[4] Chinese Acad Sci, Key Lab Biomed Imaging Sci & Syst, Shenzhen 518055, Peoples R China
来源
BIOMEDICAL PHYSICS & ENGINEERING EXPRESS | 2024年 / 10卷 / 06期
基金
中国国家自然科学基金;
关键词
brain metastasis; non-small cell lung cancer; 18F-PET/CT; radiomics; deep learning; POSITRON-EMISSION-TOMOGRAPHY; COMPUTED-TOMOGRAPHY; MANAGEMENT; RECURRENT; SYSTEM;
D O I
10.1088/2057-1976/ad7595
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objective. Approximately 57% of non-small cell lung cancer (NSCLC) patients face a 20% risk of brain metastases (BMs). The delivery of drugs to the central nervous system is challenging because of the blood-brain barrier, leading to a relatively poor prognosis for patients with BMs. Therefore, early detection and treatment of BMs are highly important for improving patient prognosis. This study aimed to investigate the feasibility of a multimodal radiomics-based method using 3D neural networks trained on F-18-FDG PET/CT images to predict BMs in NSCLC patients. Approach. We included 226 NSCLC patients who underwent F-18-FDG PET/CT scans of areas, including the lung and brain, prior to EGFR-TKI therapy. Moreover, clinical data (age, sex, stage, etc) were collected and analyzed. Shallow lung features and deep lung-brain features were extracted using PyRadiomics and 3D neural networks, respectively. A support vector machine (SVM) was used to predict BMs. The receiver operating characteristic (ROC) curve and F1 score were used to assess BM prediction performance. Main result. The combination of shallow lung and shallow-deep lung-brain features demonstrated superior predictive performance (AUC = 0.96 +/- 0.01). Shallow-deep lung-brain features exhibited strong significance (P < 0.001) and potential predictive performance (coefficient > 0.8). Moreover, BM prediction by age was significant (P < 0.05). Significance. Our approach enables the quantitative assessment of medical images and a deeper understanding of both superficial and deep tumor characteristics. This noninvasive method has the potential to identify BM-related features with statistical significance, thereby aiding in the development of targeted treatment plans for NSCLC patients.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Prediction of pathological complete response to neoadjuvant chemoimmunotherapy in non-small cell lung cancer using 18F-FDG PET radiomics features of primary tumour and lymph nodes
    Liu, Xingbiao
    Ji, Zhilin
    Zhang, Libo
    Li, Linlin
    Xu, Wengui
    Su, Qian
    BMC CANCER, 2025, 25 (01)
  • [42] Total metabolic tumor volume by 18F-FDG PET/CT for the prediction of outcome in patients with non-small cell lung cancer
    Sara Pellegrino
    Rosa Fonti
    Emanuela Mazziotti
    Luisa Piccin
    Eleonora Mozzillo
    Vincenzo Damiano
    Elide Matano
    Sabino De Placido
    Silvana Del Vecchio
    Annals of Nuclear Medicine, 2019, 33 : 937 - 944
  • [43] Indeterminate pleural metastasis on contrast-enhanced chest CT in non-small cell lung cancer: improved differential diagnosis with 18F-FDG PET/CT
    Jung, Min-Young
    Chong, Ari
    Seon, Hyun Ju
    Choi, Song
    Kim, Yun-Hyeon
    Shin, Sang Soo
    Kim, Jin Woong
    Bom, Hee-Seung
    ANNALS OF NUCLEAR MEDICINE, 2012, 26 (04) : 327 - 336
  • [44] Radiomics-Based Deep Learning Prediction of Overall Survival in Non-Small-Cell Lung Cancer Using Contrast-Enhanced Computed Tomography
    Hou, Kuei-Yuan
    Chen, Jyun-Ru
    Wang, Yung-Chen
    Chiu, Ming-Huang
    Lin, Sen-Ping
    Mo, Yuan-Heng
    Peng, Shih-Chieh
    Lu, Chia-Feng
    CANCERS, 2022, 14 (15)
  • [45] CT radiomics-based model for predicting TMB and immunotherapy response in non-small cell lung cancer
    Wang, Jiexiao
    Wang, Jialiang
    Huang, Xiang
    Zhou, Yanfei
    Qi, Jian
    Sun, Xiaojun
    Nie, Jinfu
    Hu, Zongtao
    Wang, Shujie
    Hong, Bo
    Wang, Hongzhi
    BMC MEDICAL IMAGING, 2024, 24 (01)
  • [46] CT radiomics-based model for predicting TMB and immunotherapy response in non-small cell lung cancer
    Jiexiao Wang
    Jialiang Wang
    Xiang Huang
    Yanfei Zhou
    Jian Qi
    Xiaojun Sun
    Jinfu Nie
    Zongtao Hu
    Shujie Wang
    Bo Hong
    Hongzhi Wang
    BMC Medical Imaging, 24
  • [47] Baseline 18F-FDG PET/CT parameters in predicting the efficacy of immunotherapy in non-small cell lung cancer
    Zheng, Lu
    Bian, Yanzhu
    Hu, Yujing
    Tian, Congna
    Zhang, Xinchao
    Li, Shuheng
    Yang, Xin
    Qin, Yanan
    FRONTIERS IN MEDICINE, 2025, 12
  • [48] Imaging of proliferation with 18F-FLT PET/CT versus 18F-FDG PET/CT in non-small-cell lung cancer
    Yang, Wenfeng
    Zhang, Yongming
    Fu, Zheng
    Yu, Jinming
    Sun, Xiaorong
    Mu, Dianbin
    Han, Anqin
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 (07) : 1291 - 1299
  • [49] Predictive value of 18F-FDG PET/CT radiomics for EGFR mutation status in non-small cell lung cancer: a systematic review and meta-analysis
    Ma, Ning
    Yang, Weihua
    Wang, Qiannan
    Cui, Caozhe
    Hu, Yiyi
    Wu, Zhifang
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [50] 18F-FDG PET/CT Evaluation of Non-Small Cell Lung Cancer Initial Experience from Johannesburg
    Evbuomwan, Osayande
    Ayeni, Olusegun A.
    Purbhoo, Khushica
    Vangu, Mboyo D. T.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S495 - S495